why these biotech, pharma stocks have more upside: analyst
Published 3 years ago • 2.5K plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
4:18
biotech stocks have been overlooked for the past year and a half, says jefferies' michael yee
-
6:35
biotech stocks will get a tailwind from rate cuts, says stempoint's michelle ross
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
1:04
an fda approval could be worth over $100 billion to this biotech stock
-
1:12
biotech stocks are seeing a smaller sell-off compared to other sectors
-
5:02
what investors should look for in biotech stocks
-
5:32
these are the stocks to buy for the next 10 years
-
2:59
3-stock lunch: apple, amazon and tesla
-
4:00
takeda to keep pushing for china biotech partnership
-
4:12
biotech stocks will trade depending on the state of the epidemic: bernstein's ronny gal
-
5:00
biotech analyst discusses her top stock picks: biogen & sarepta therapeutics
-
4:13
mizuho's jared holz on finding opportunities in the biotech space
-
5:07
biotech companies need capital, but challenge is finding high quality management teams: cowen ceo
-
3:48
key biotech stocks to watch this week
-
5:52
biotech boom ahead in 2024, top jefferies analyst predicts on heels of bristol meyers-karuna deal
-
2:48
the regulatory impact on biotech and health care stocks
-
7:09
under-the-radar biotech bets
-
0:31
penny stocks explained
-
5:01
acceleration of economic activity will start in mid-2021: bernstein analyst
-
4:46
there's a crop of great biotech companies ready to be acquired, says mpm's christiana bardon
-
2:48
biotech is going to have a hard time until the end of rate cycle, says e squared's les funtleyder
-
7:19
how stock exchange and biotech stocks could benefit from an inflation uptick